Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome - 06/11/15
Doi : 10.1016/j.jaci.2015.07.003
Camila D. Odio, BA a, Ki Lee Milligan, MD a, Katherine McGowan, BS a, Amanda K. Rudman Spergel, MD a, Rachel Bishop, MD, MPH b, Lisa Boris, CRNP c, Amanda Urban, CRNP c, Pamela Welch, RN c, Theo Heller, MD d, David Kleiner, MD e, Mary Anne Jackson, MD f, Steven M. Holland, MD a, Alexandra F. Freeman, MD a 
a National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md
b National Eye Institute, NIH, Bethesda, Md
c Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, Frederick, Md
d National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Md
e National Cancer Institute, NIH, Bethesda, Md
f Children's Mercy Hospital, Bethesda, Md
| This study was funded in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and the National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland. This project has been funded in part with federal funds from the National Cancer Institute, NIH (contract no. HHSN261200800001E). C.D.O. was funded through the NIH Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and by generous contributions to the Foundation for the NIH from Pfizer, Inc, The Doris Duke Charitable Foundation, The Alexandria Real Estate Equities, Inc, Mr and Mrs Joel S. Marcus, and the Howard Hughes Medical Institute, as well as other private donors. For a complete list, please visit the foundation's Web site at: medical-research-scholars-program. The views expressed in this article are those of the authors and do not reflect the official policy of the US government. This research was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. |
|
| Disclosure of potential conflicts of interest: The authors declare that they have no relevant conflicts of interest. |
© 2015
Publié par Elsevier Masson SAS.
Vol 136 - N° 5
P. 1411 - novembre 2015 Retour au numéro
Article précédent
- Measuring the effect of asthma control on exacerbations and health resource use
- Patrick W. Sullivan, Jonathan D. Campbell, Gary Globe, Vahram H. Ghushchyan, Bruce Bender, Michael Schatz, Yun Chon, J. Michael Woolley, David J. Magid
- CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier
- Terufumi Kubo, Paulina Wawrzyniak, Hideaki Morita, Kazunari Sugita, Kerstin Wanke, Jeannette I. Kast, Can Altunbulakli, Beate Rückert, Bogdan Jakiela, Marek Sanak, Mübeccel Akdis, Cezmi A. Akdis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?